Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-04 7:46 pm Purchase |
2025-02-28 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 80,864,315 21.600% |
7,098,241 (+9.62%) |
Filing History |
| 2024-11-14 3:32 pm Sale |
2024-09-30 | 13G | Standard BioTools Inc. LAB |
Indaba Capital Management, L.P. | 2,641,379 0.700% |
-5,333,995 (-66.88%) |
Filing History |
| 2024-11-12 6:01 pm Unchanged |
2024-09-30 | 13G | Standard BioTools Inc. LAB |
The Vanguard Group | 17,292,092 4.650% |
0 (Unchanged) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Standard BioTools Inc. LAB |
BLACKROCK INC BLK |
22,452,115 6.000% |
0 (Unchanged) |
Filing History |
| 2024-11-04 1:59 pm Purchase |
2024-09-30 | 13G | Standard BioTools Inc. LAB |
The Vanguard Group | 17,292,092 4.650% |
13,158,153 (+318.30%) |
Filing History |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Standard BioTools Inc. LAB |
BLACKROCK INC BLK |
22,452,115 6.000% |
20,434,905 (+1013.03%) |
Filing History |
| 2024-10-21 4:26 pm Sale |
2024-09-30 | 13G | Standard BioTools Inc. LAB |
MILLENNIUM MANAGEMENT LLC | 6,984,232 1.900% |
-8,052,833 (-53.55%) |
Filing History |
| 2024-08-14 8:54 pm Purchase |
2024-08-12 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 73,766,074 19.770% |
3,364,737 (+4.78%) |
Filing History |
| 2024-06-03 5:20 pm Sale |
2024-05-30 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 70,401,337 18.910% |
-5,936,401 (-7.78%) |
Filing History |
| 2024-05-22 4:54 pm Purchase |
2024-05-17 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 76,337,738 20.370% |
1,802,072 (+2.42%) |
Filing History |
| 2024-03-20 6:05 pm Purchase |
2024-03-18 | 13G | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 58,651,170 15.300% |
29,544,805 (+101.51%) |
Filing History |
| 2024-03-20 5:25 pm Purchase |
2024-03-18 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 74,535,666 19.250% |
9,238,070 (+14.15%) |
Filing History |
| 2024-02-26 4:15 pm Purchase |
2024-02-16 | 13G | Standard BioTools Inc. LAB |
MILLENNIUM MANAGEMENT LLC | 15,037,065 5.200% |
15,037,065 (New Position) |
Filing History |
| 2024-02-14 3:32 pm Purchase |
2023-12-31 | 13G | Standard BioTools Inc. LAB |
Indaba Capital Management, L.P. | 7,975,374 9.900% |
80,623 (+1.02%) |
Filing History |
| 2024-02-13 5:14 pm Purchase |
2023-12-29 | 13G | Standard BioTools Inc. LAB |
The Vanguard Group | 4,133,939 5.210% |
177,971 (+4.50%) |
Filing History |
| 2024-01-12 2:04 pm Purchase |
2024-01-05 | 13D | Standard BioTools Inc. LAB |
Neuberger Berman Group LLC | 4,382,584 11.000% |
46,481 (+1.07%) |
Filing History |
| 2024-01-09 5:13 pm Purchase |
2024-01-05 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 65,297,596 19.710% |
27,715,250 (+73.75%) |
Filing History |
| 2024-01-09 4:46 pm Purchase |
2024-01-05 | 13G | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 29,106,365 9.500% |
20,817,249 (+251.14%) |
Filing History |
| 2024-01-08 5:00 pm Sale |
2024-01-05 | 13D | Standard BioTools Inc. LAB |
Caligan Partners LP | 7,042,413 2.400% |
-755,041 (-9.68%) |
Filing History |
| 2023-11-22 4:15 pm Unchanged |
2023-10-04 | 13D | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% |
0 (Unchanged) |
Filing History |